Strontium ranelate may slow progression of osteoarthritis

11/18/2012 | Healio

Researchers have found patients who took 1 to 2 grams of strontium ranelate daily showed lower cartilage loss measures at one year compared with those in the placebo group. Improved physical function and less pain were also seen in strontium ranelate-treated patients, suggesting that the drug may help delay the progression of knee osteoarthritis.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ